Clinical Trial Update: Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating BL-M07D1 in HER2-expressing malignant solid tumors, with recruitment across several tumor types including endometrial and ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Breast Cancer
• Cervical Cancer
• Endometrial Cancer
• Gastric Cancer
• Lung Cancer
• Ovarian Cancer
• Urothelial Carcinoma

Drugs mentioned

• BL-M07D1

Snippet

Sponsor: SystImmune Inc. | Conditions: Endometrial Cancer, Cervical Cancer | Phase 1 | Status: RECRUITING